Vaxxas appoints veteran vaccine leader to board as it advances needle-free vaccine patch

Australian biotechnology company Vaxxas Pty Ltd, has announced the appointment of Mr Brent MacGregor as Independent Non-Executive Director to the Vaxxas Board. Mr MacGregor brings deep global experience in vaccine and medical device commercialisation to Vaxxas as the company advances its high-density microarray patch (HD-MAP) technology for self-administered vaccination towards market.

Mr MacGregor is CEO of Medical Developments International (ASX: MVP), an Australian company committed to developing and distributing medicines and medical devices, including Penthrox, known as ‘The Green Whistle’ for acute pain, and a range of spacers for asthma and COPD (chronic obstructive pulmonary disease) sufferers. These…